U.S. market Closed. Opens in 17 hours 19 minutes

TERN | Terns Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/A1.00MN/AN/AN/A
Cost of Revenue881.00K1.03M512.00K394.00K195.00KN/A
Gross Profit-881.00K-1.03M488.00K-394.00K-195.00KN/A
Operating Expenses101.68M62.03M50.86M37.02M70.20M18.45M
Selling, General & Admin38.18M22.41M19.55M9.00M8.66M3.90M
Research & Development63.50M39.62M31.31M28.03M61.53M14.55M
Other Operating ExpensesN/A-68.00K40.00K-2.79M154.00K38.00K
Operating Income-102.56M-62.03M-49.86M-37.02M-70.20M-18.45M
Other Expenses / Income12.59M2.04M210.00K-2.73M1.36M38.00K
Before Tax Income-89.97M-59.99M-49.65M-39.76M-68.84M-18.09M
Income Tax Expenses239.00K358.00K508.00K813.00K-20.00K-67.00K
Net Income-90.21M-60.34M-50.16M-40.57M-68.82M-17.71M
Interest ExpensesN/A-2.04MN/AN/AN/AN/A
Basic Shares Outstanding71.26M36.03M25.27M25.13M25.10M23.97M
Diluted Shares Outstanding71.26M36.03M25.27M25.13M25.10M23.97M
EBITDA-101.68M-62.03M-49.86M-36.63M-70.00M-18.39M
EBITDA Margin0.00%0.00%-4,986.00%0.00%0.00%0.00%
EBIT-89.97M-62.03M-49.65M-39.76M-68.84M-17.78M
EBIT Margin0.00%0.00%-4,965.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙